Ketamine Completed Phase 4 Trials for Depression, Anxiety / Depression / Major Depressive Disorder (MDD) Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT02544607Ketamine for Depression: An MRI Study